About
BenevolentAI is a UK-based company that leverages a proprietary knowledge graph and machine learning to accelerate drug discovery and development. Their platform analyzes complex biomedical data and scientific literature to identify promising drug candidates and targets, supporting R&D decisions for pharmaceutical and biotechnology companies. BenevolentAI differentiates itself through a decade of investment in building a uniquely comprehensive and interconnected life science intelligence system.
Stock Price
BAIData provided by TradingView & Yahoo Finance
Focus Areas
Technology Focus
healthcare drug discovery ml infrastructure
Key People
J
Joerg Moeller Quick Stats
Founded 2013
Status public
Type scaleup
Explore More
Similar Companies
Atomic AI
San Francisco, United States
89%
4 shared categories
3 shared AI types
Healthcare AIDrug Discovery +2
Valo Health
Boston, United States
79%
3 shared categories
3 shared AI types
Healthcare AIDrug Discovery +1
Exscientia
Oxford, United Kingdom
75%
3 shared categories
2 shared AI types
Same country
Drug DiscoveryHealthcare AI +1
54gene
Lagos, Nigeria
75%
3 shared categories
3 shared AI types
Healthcare AIDrug Discovery +1